Riihonen Riikka, Supuran Claudiu T, Parkkila Seppo, Pastorekova Silvia, Väänänen H Kalervo, Laitala-Leinonen Tiina
Bone Biology Research Consortium, Department of Anatomy, Institute of Biomedicine, Kiinamyllynkatu 10, FI-20520 Turku, Finland.
Bone. 2007 Apr;40(4):1021-31. doi: 10.1016/j.bone.2006.11.028. Epub 2006 Dec 22.
Osteoclasts are multinucleated bone-resorbing cells that use multiple pH regulation mechanisms to create an acidic pH in the resorption lacuna. Carbonic anhydrase II and vacuolar H(+)-ATPases produce and transport protons, while chloride channels provide a Cl(-) flux into the resorption site. These activities are required for inorganic matrix dissolution that precedes enzymatic removal of organic bone matrix. In other cell types it has become evident that carbonic anhydrase isoenzymes interact with AE proteins to form transport metabolons that regulate intracellular pH. Membrane-bound carbonic anhydrase isoenzymes may also compensate for the lack of cytoplasmic carbonic anhydrase II. Therefore, our goal was to explore the expression of membrane-bound carbonic anhydrase (CA) isoenzymes CA IV, CA IX, CA XII and CA XIV in bone-resorbing osteoclasts. Immunohistochemistry and confocal microscopy showed expression of CA IV, CA XII and CA XIV in cultured rat and human osteoclasts. To confirm these results, RT-PCR was used. Immunohistochemistry revealed distinct staining patterns for CA IV, CA XII and CA XIV in rat trabecular bone specimens. A plasma membrane staining was observed in bone lining cells with the CA XII antibody while osteoclast plasma membranes were stained with CA IV and CA XIV antibodies. Confocal microscopy of cultured human osteoclasts showed a punctated intracellular CA IV staining and a perinuclear CA XIV staining while no CA IX or CA XII staining was observed. To evaluate the physiological role of membrane-bound CAs in osteoclasts, we used PCS, a novel membrane-impermeable CA inhibitor. Increased osteoclast number and bone resorption activity was observed in rat osteoclast cultures exposed to a low concentration of PCS while higher concentrations affected cell survival. PCS treatment also disturbed intracellular acidification in osteoclasts, as determined by live cell microscopy. In conclusion, our data shows that membrane-bound carbonic anhydrase isoenzymes CA IV and CA XIV are expressed both at mRNA and protein levels in osteoclasts in vivo and in vitro. In addition, the inhibitor experiments provide novel evidence to support the hypothesis that intracellular pH regulation in osteoclasts may indeed involve transport metabolons.
破骨细胞是多核的骨吸收细胞,它们利用多种pH调节机制在吸收陷窝中产生酸性pH值。碳酸酐酶II和液泡H(+)-ATP酶产生并转运质子,而氯离子通道则使Cl(-)流入吸收部位。这些活动是无机基质溶解所必需的,而无机基质溶解先于有机骨基质的酶促去除。在其他细胞类型中,已经很明显碳酸酐酶同工酶与AE蛋白相互作用形成调节细胞内pH值的转运代谢体。膜结合的碳酸酐酶同工酶也可能补偿细胞质碳酸酐酶II的缺乏。因此,我们的目标是探索膜结合碳酸酐酶(CA)同工酶CA IV、CA IX、CA XII和CA XIV在骨吸收破骨细胞中的表达。免疫组织化学和共聚焦显微镜显示CA IV、CA XII和CA XIV在培养的大鼠和人类破骨细胞中有表达。为了证实这些结果,使用了逆转录聚合酶链反应(RT-PCR)。免疫组织化学揭示了大鼠小梁骨标本中CA IV、CA XII和CA XIV的不同染色模式。用CA XII抗体在骨衬细胞中观察到质膜染色,而用CA IV和CA XIV抗体对破骨细胞质膜进行了染色。培养的人类破骨细胞的共聚焦显微镜显示细胞内CA IV呈点状染色而CA XIV呈核周染色,而未观察到CA IX或CA XII染色。为了评估膜结合CA在破骨细胞中的生理作用,我们使用了PCS,一种新型的膜不可渗透的CA抑制剂。在暴露于低浓度PCS的大鼠破骨细胞培养物中观察到破骨细胞数量增加和骨吸收活性增强,而较高浓度则影响细胞存活。通过活细胞显微镜观察确定,PCS处理也扰乱了破骨细胞内的酸化。总之,我们的数据表明,膜结合碳酸酐酶同工酶CA IV和CA XIV在体内和体外破骨细胞的mRNA和蛋白质水平均有表达。此外,抑制剂实验提供了新的证据来支持破骨细胞内pH调节可能确实涉及转运代谢体的假说。